Observational studyDiabetologia2021
Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study.
Registry-linked trialOpen access · hybridAbstract readMulticenter StudyObservational Study
In one paragraph
Observational study in Diabetologia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04324736 ("Coronavirus SARS-CoV2 and Diabetes Outcomes"), which is not on this map. Cited by 90 papers, 17 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed, 17 pooled it
10.3field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
"Coronavirus SARS-CoV2 and Diabetes Outcomes" : CORONADO
Who cites it
90 citing papers in PubMed, 17 syntheses or guidelines pooled it, 168 citations in OpenAlex.
- The Effect of Antihyperglycemic Medications on COVID-19: A Meta-analysis and Systematic Review from Observational Studies.Therapeutic innovation & regulatory science · 2024 · on this mapPooled it
- Risk phenotypes of diabetes and association with COVID-19 severity and death: an update of a living systematic review and meta-analysis.Diabetologia · 2023Pooled it
- Effect of Antidiabetic Therapy on Clinical Outcomes of COVID-19 Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis.The Annals of pharmacotherapy · 2023 · on this mapPooled it
- Noninsulin-based antihyperglycemic medications in patients with diabetes and COVID-19: A systematic review and meta-analysis.Journal of diabetes · 2023 · on this mapPooled it
- Association of Glucose-Lowering Drugs With Outcomes in Patients With Diabetes Before Hospitalization for COVID-19: A Systematic Review and Network Meta-analysis.JAMA network open · 2022Pooled it
- The association between macrovascular complications and intensive care admission, invasive mechanical ventilation, and mortality in people with diabetes hospitalized for coronavirus disease-2019 (COVID-19).Cardiovascular diabetology · 2022Pooled it
- Preadmission use of antidiabetic medications and mortality among patients with COVID-19 having type 2 diabetes: A meta-analysis.Metabolism: clinical and experimental · 2022Pooled it
- Impact of diabetes on COVID-19 mortality and hospital outcomes from a global perspective: An umbrella systematic review and meta-analysis.Endocrinology, diabetes & metabolism · 2022Pooled it
- Pre-existing diabetic retinopathy as a prognostic factor for COVID-19 outcomes amongst people with diabetes: A systematic review.Diabetes research and clinical practice · 2022Pooled it
- Association of statin and/or renin-angiotensin-aldosterone system modulating therapy with mortality in adults with diabetes admitted to hospital with COVID-19: A retrospective multicentre European study.Diabetes & metabolic syndrome · 2022 · on this mapPooled it
- Association Between Anti-diabetic Agents and Clinical Outcomes of COVID-19 in Patients with Diabetes: A Systematic Review and Meta-Analysis.Archives of medical research · 2022Pooled it
- The Association Between Antidiabetic Agents and Clinical Outcomes of COVID-19 Patients With Diabetes: A Bayesian Network Meta-Analysis.Frontiers in endocrinology · 2022 · on this mapPooled it
- Managing diabetes in diabetic patients with COVID: where do we start from?Acta diabetologica · 2021Pooled it
- Pre-admission glucagon-like peptide-1 receptor agonist (GLP-1RA) and mortality from coronavirus disease 2019 (Covid-19): A systematic review, meta-analysis, and meta-regression.Diabetes research and clinical practice · 2021Pooled it
- Dipeptidyl Peptidase-4 Inhibitors and COVID-19-Related Deaths among Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Observational Studies.Endocrinology and metabolism (Seoul, Korea) · 2021Pooled it
- The effect of metformin on mortality and severity in COVID-19 patients with diabetes mellitus.Diabetes research and clinical practice · 2021 · on this mapPooled it
- Mortality Risk of Antidiabetic Agents for Type 2 Diabetes With COVID-19: A Systematic Review and Meta-Analysis.Frontiers in endocrinology · 2021Pooled it
- Impact of diabetes on COVID-19 prognosis beyond comorbidity burden: the CORONADO initiative.Diabetologia · 2022Trial
- Association of Inpatient Diabetes Specialist Consultation with Clinical Outcomes in Patients with Diabetes Hospitalized for Lower Respiratory Tract Infections: A Retrospective Cohort Study.Journal of clinical medicine · 2026Article
- Metformin alleviates inflammatory response and severity rate of COVID-19 infection in elderly individuals.Scientific reports · 2025Article
30 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
43 authors at 17 institutions in 4 countries.
Matthieu Wargnyl'institut du thorax, Inserm, CNRS, UNIV Nantes, CHU Nantes, Nantes, France.ORCID 0000-0001-6027-9486
Louis PotierDépartement d'Endocrinologie, Diabétologie et Nutrition, Hôpital Bichat, Assistance Publique Hôpitaux de Paris, Paris, France.ORCID 0000-0001-6268-7360
Pierre GourdyDépartement d'Endocrinologie, Diabétologie et Nutrition, CHU Toulouse, Toulouse, France.ORCID 0000-0002-5362-3813
Matthieu Pichelinl'institut du thorax, Inserm, CNRS, UNIV Nantes, CHU Nantes, Nantes, France.ORCID 0000-0002-6822-6132
Coralie AmadouDépartement de Diabétologie, Centre Hospitalier Sud Francilien, Corbeil-Essonnes, France.ORCID 0000-0002-0581-7592
Pierre-Yves BenhamouService Endocrinologie-Diabétologie-Nutrition, CHU Grenoble, Grenoble, France.
Jean-Baptiste BonnetDépartement d'Endocrinologie, Diabète, Nutrition et CIC Inserm 1411, CHU de Montpellier, Montpellier, France.
Lyse BordierDépartement de Diabétologie, H.I.A. Begin, Saint Mandé, France.
Olivier BourronSorbonne Université, Paris, France.ORCID 0000-0001-7348-7161
Claude ChaumeilFédération Française des Diabétiques (FFD), Paris, France.
Nicolas ChevalierUniversité Côte d'Azur, CHU, Inserm U1065, C3M, Nice, France.ORCID 0000-0001-7160-4301
Patrice DarmonService d'Endocrinologie, Maladies Métaboliques et Nutrition, Hôpital de la Conception, Assistance Publique Hôpitaux de Marseille, Marseille, France.ORCID 0000-0003-1726-2296
Blandine DelenneService d'Endocrinologie, Diabétologie et Maladies Métaboliques, Centre Hospitalier d'Aix-en-Provence, Aix-en-Provence, France.
Delphine DemarsyService Endocrinologie-Diabétologie, Centre Hospitalier de la Côte Basque, Bayonne, France.
Marie DumasService Endocrinologie-Diabétologie, Hôpital Saint Vincent de Paul Lille, Lille, France.
Olivier DupuyService de Diabétologie Endocrinologie, Hôpital Paris Saint-Joseph, Paris, France.ORCID 0000-0001-8731-3242
Anna Flaus-FurmaniukService d'Endocrinologie - Diabétologie, Site Felix Guyon, CHU de la Réunion, Saint-Denis de la Réunion, France.
Jean-François GautierCentre de Recherche des Cordeliers, Inserm, U-1138, Université de Paris, Paris, France.ORCID 0000-0001-6458-2001
Anne-Marie GuedjService des Maladies Métaboliques et Endocriniennes, CHU de Nîmes, Université de Montpellier, Nîmes, France.
Nathalie JeandidierService d'Endocrinologie, Diabétologie et Nutrition, Hôpitaux Universitaires de Strasbourg, UdS, Strasbourg, France.
Etienne LargerService de Diabétologie et Immunologie Clinique, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, Centre-Université de Paris, Paris, France.
Jean-Philippe Le BerreService de Diabétologie et d'Endocrinologie, Médipôle, Villeurbanne, France.
Myriam LungoService d'Endocrinologie et de Diabétologie, Centre Hospitalier de Bastia, Bastia, France.
Nathanaëlle MontanierService d'Endocrinologie, Centre Hospitalier du Forez, Montbrison, France.
Philippe MoulinHôpital Cardiovasculaire Louis Pradel, Hospices Civils de Lyon, Inserm UMR 1060 Carmen, Université Claude Bernard Lyon 1, Lyon, France.
Françoise PlatService d'Endocrinologie et Maladies Métaboliques, Centre Hospitalier d'Avignon, Avignon, France.
Vincent RigalleauEndocrinology-Nutrition Department, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France.
René RobertUniversité de Poitiers; CIC Inserm 1402; Médecine Intensive Réanimation, Centre Hospitalier Universitaire de Poitiers, Poitiers, France.ORCID 0000-0001-5989-5409
Dominique Seret-BéguéService de Diabétologie, Endocrinologie et Nutrition, Centre Hospitalier de Gonesse, Gonesse, France.
Pierre SérusclatService d'Endocrinologie, Diabétologie et Maladies Métaboliques, Groupe Hospitalier Mutualiste Les Portes du Sud, Venissieux, France.
Sarra Smatil'institut du thorax, Inserm, CNRS, UNIV Nantes, CHU Nantes, Nantes, France.
Jean-François ThébautFédération Française des Diabétiques (FFD), Paris, France.ORCID 0000-0003-4926-9943
Blandine TramuntDépartement d'Endocrinologie, Diabétologie et Nutrition, CHU Toulouse, Toulouse, France.
Camille VatierAssistance Publique Hôpitaux de Paris, Saint-Antoine Hospital, Reference Center of Rare Diseases of Insulin Secretion and Insulin Sensitivity (PRISIS), Department of Endocrinology, Paris, France.ORCID 0000-0001-8342-1596
Fritz-Line VelayoudomService d'Endocrinologie, Diabétologie et Métabolisme, Centre Hospitalier Universitaire de Guadeloupe, Pointe-à-Pitre, France.
Bruno VergèsService Endocrinologie, Diabétologie et Maladies Métaboliques, Hôpital du Bocage, Dijon, France.
Patrice WiniszewskiService d'Endocrinologie, Diabétologie et Nutrition, Hôpital Nord Franche-Comté, Trévenans, France.
Audrey ZabulonService d'Endocrinologie et Diabétologie, CHU de Martinique, Fort-de-France, France.
Pierre-Antoine GourraudCHU de Nantes, Inserm, CIC 1413, Pôle Hospitalo-Universitaire 11: Santé Publique, Clinique des Données, Nantes, France.ORCID 0000-0003-1131-9554
Ronan RousselDépartement d'Endocrinologie, Diabétologie et Nutrition, Hôpital Bichat, Assistance Publique Hôpitaux de Paris, Paris, France.ORCID 0000-0003-2292-8363
Bertrand Carioul'institut du thorax, Inserm, CNRS, UNIV Nantes, CHU Nantes, Nantes, France. bertrand.cariou@univ-nantes.fr.
Samy Hadjadjl'institut du thorax, Inserm, CNRS, UNIV Nantes, CHU Nantes, Nantes, France. samy.hadjadj@univ-nantes.fr.ORCID 0000-0001-7110-6994
CORONADO investigators
Inserm · FRCentre National de la Recherche Scientifique · FRUniversité Toulouse III - Paul Sabatier · FRHôpital Nord · FRInstitut Régional d'Administration de Bastia · FRUniversité Claude Bernard Lyon 1 · FRUniversité Paris Cité · FRCentre Hospitalier de Gonesse · FRCentre Hospitalier de la Côte Basque · FRCentre Hospitalier du Pays d'Aix · FRCentre Hospitalier Universitaire de La Réunion · FRCentre Hospitalier Universitaire Pointe-à-Pitre · GPCouncil of Independent Colleges · USHôpital Paris Saint-Joseph · FRUniversité de Bordeaux · FRUniversité de Montpellier · FRUniversité Paris-Saclay · FR
Funding
No grant is acknowledged in the PubMed record.
Abstract
aims/hypothesisThis is an update of the results from the previous report of the CORONADO (Coronavirus SARS-CoV-2 and Diabetes Outcomes) study, which aims to describe the outcomes and prognostic factors in patients with diabetes hospitalised for coronavirus disease-2019 (COVID-19).
methodsThe CORONADO initiative is a French nationwide multicentre study of patients with diabetes hospitalised for COVID-19 with a 28-day follow-up. The patients were screened after hospital admission from 10 March to 10 April 2020. We mainly focused on hospital discharge and death within 28 days.
resultsWe included 2796 participants: 63.7% men, mean age 69.7 ± 13.2 years, median BMI (25th-75th percentile) 28.4 (25.0-32.4) kg/m CONCLUSIONS/
interpretationIn patients with diabetes hospitalised for COVID-19, we established prognostic factors for hospital discharge and death that could help clinicians in this pandemic period.
trial registrationClinicaltrials.gov identifier: NCT04324736.
Indexed as
Patient DischargeAgedAged, 80 and overCOVID-19Diabetes ComplicationsDiabetes MellitusFemaleFollow-Up StudiesFranceHospitalizationHospital MortalityHumansLength of StayMaleMiddle AgedPrognosisAdmission plasma glucoseCOVID-19DeathDiabetesDischargeHbA1cHome dischargeMechanical ventilation
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
NCT04324736ClinicalTrials.gov
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.